Karaiskos, I.; Gkoufa, A.; Polyzou, E.; Schinas, G.; Athanassa, Z.; Akinosoglou, K.
High-Dose Nebulized Colistin Methanesulfonate and the Role in Hospital-Acquired Pneumonia Caused by Gram-Negative Bacteria with Difficult-to-Treat Resistance: A Review. Microorganisms 2023, 11, 1459.
https://doi.org/10.3390/microorganisms11061459
AMA Style
Karaiskos I, Gkoufa A, Polyzou E, Schinas G, Athanassa Z, Akinosoglou K.
High-Dose Nebulized Colistin Methanesulfonate and the Role in Hospital-Acquired Pneumonia Caused by Gram-Negative Bacteria with Difficult-to-Treat Resistance: A Review. Microorganisms. 2023; 11(6):1459.
https://doi.org/10.3390/microorganisms11061459
Chicago/Turabian Style
Karaiskos, Ilias, Aikaterini Gkoufa, Elena Polyzou, Georgios Schinas, Zoe Athanassa, and Karolina Akinosoglou.
2023. "High-Dose Nebulized Colistin Methanesulfonate and the Role in Hospital-Acquired Pneumonia Caused by Gram-Negative Bacteria with Difficult-to-Treat Resistance: A Review" Microorganisms 11, no. 6: 1459.
https://doi.org/10.3390/microorganisms11061459
APA Style
Karaiskos, I., Gkoufa, A., Polyzou, E., Schinas, G., Athanassa, Z., & Akinosoglou, K.
(2023). High-Dose Nebulized Colistin Methanesulfonate and the Role in Hospital-Acquired Pneumonia Caused by Gram-Negative Bacteria with Difficult-to-Treat Resistance: A Review. Microorganisms, 11(6), 1459.
https://doi.org/10.3390/microorganisms11061459
